The safety of fluoxetine during pregnancy and lactation

Teratology. 1996 May;53(5):304-8. doi: 10.1002/(SICI)1096-9926(199605)53:5<304::AID-TERA4>3.0.CO;2-0.

Authors

I Nulman¹, G Koren

Affiliation

¹ Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.

PMID: 8879088
DOI: 10.1002/(SICI)1096-9926(199605)53:5<304::AID-TERA4>3.0.CO;2-0

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Abnormalities, Drug-Induced / etiology
Animals
Antidepressive Agents, Second-Generation / adverse effects*
Antidepressive Agents, Second-Generation / pharmacokinetics
Antidepressive Agents, Second-Generation / toxicity
Breast Feeding
Female
Fluoxetine / adverse effects*
Fluoxetine / pharmacokinetics
Fluoxetine / toxicity
Humans
Infant, Newborn
Lactation
Mice
Pregnancy
Rats
Safety
Selective Serotonin Reuptake Inhibitors / adverse effects*
Selective Serotonin Reuptake Inhibitors / pharmacokinetics
Selective Serotonin Reuptake Inhibitors / toxicity
Teratogens / pharmacokinetics
Teratogens / toxicity*

Substances

Antidepressive Agents, Second-Generation
Serotonin Uptake Inhibitors
Teratogens
Fluoxetine